More recently, it has been shown that PCN (a rodent-specific activator of the PXR) inhibits the expression of several – but not all – NF-κB-dependent inflammatory genes in a mouse model of inflammatory bowel disease, an effect lost in PXR−/− mice [20]. The gene discussed is NR1I2; the disease is inflammatory bowel disease.